首页|期刊导航|中国人兽共患病学报|2021-2024年北京市朝阳区临床分离肺炎克雷伯菌耐药表型及全基因组序列分析

2021-2024年北京市朝阳区临床分离肺炎克雷伯菌耐药表型及全基因组序列分析OA

Drug resistance phenotypes and whole genome sequences of clinical isolates of Klebsiella pneumoniae in Chaoyang District,Beijing,2021-2024

中文摘要英文摘要

目的 了解住院患者不同部位临床分离的肺炎克雷伯菌药敏情况,分析菌株的耐药表型、耐药基因和高毒力相关基因.方法 收集北京市朝阳区2021-2024年临床分离的肺炎克雷伯菌115株,进行药敏试验和全基因组测序,用Microo-bench病原微生物分析工作站对原始数据进行基因组分析(无参拼接);应用SPSS 27.0软件对数据进行统计学分析.结果 本研究中肺炎克雷伯菌耐药率呈逐年上升趋势,对19种抗生素的耐药率超过50%;耐碳青霉烯类肺炎克雷伯菌(carbapenem re-sistant Klebsiella pneumoniae,CRKP)检出率为58.26%;分子分型显示CC258克隆复合体为本地区主要流行序列型(45.22%),且均为ST11型菌株,荚膜血清型以K25(17.39%)、K64(15.65%)和K1(12.17%)为主;本研究中发现14株高毒力肺炎克雷伯菌(hy-pervirulent Klebsiella pneumoniae,hvKP),其中3株为耐碳青霉烯类高毒力肺炎克雷伯菌(hypervirulent carbapenem-resistant Klebsiella pneumoniae,HCKP).结论 肺炎克雷伯菌耐药性显示出持续增强的严峻态势,HCKP的出现,提示需警惕"超级细菌"的进化风险.医院应加强临床合理用药,整合分子监测与精准干预以遏制耐药克隆传播.

This study was aimed at understanding the drug sensitivity of Klebsiella pneumoniae clinical isolates from hospitalized patients,and analyzing their drug resistance phenotypes,drug resistance genes,and high virulence genes.A total of 115 K.pneu-moniae strains clinically isolated from Chaoyang District,Beijing,from 2021 to 2024 were collected for drug sensitivity testing and whole genome sequencing.The original data were analyzed in the Microobench pathogen analysis workstation(without reference splic-ing).Statistical analysis was conducted in SPSS 27.0 software.The resistance rate of K.pneumoniae increased each year,and the resis-tance rates to 19 types of antibiotics exceeded 50%.The detection rate of carbapenem-resistant Klebsiella pneumoniae(CRKP)was 58.26%.Molecular typing revealed that the CC258 clone complex was the most prevalent sequence type in this region(45.22%),and all were ST11-type strains.A total of 14 strains of highly virulent K.pneumoniae(hvKP)were found,three of which were hyperviru-lent carbapenem-resistant K.pneumoniae(HCKP).The drug resistance of K.pneumoniae showed a continually increasing trend,and the emergence of HCKP suggested a need for vigilance regarding the evolutionary risks of"superbugs."Hospitals should strengthen clinical rational drug use,and integrate molecular monitoring and precise intervention to curb the spread of drug-resistant clones.

顾琳;赵剑虹;高艳;黄平;郭启明

北京市朝阳区疾病预防控制中心,北京 100021北京市朝阳区疾病预防控制中心,北京 100021北京市朝阳区疾病预防控制中心,北京 100021北京市朝阳区疾病预防控制中心,北京 100021北京市朝阳区疾病预防控制中心,北京 100021

医药卫生

肺炎克雷伯菌耐药表型全基因组测序耐药基因高毒力

Klebsiella pneumoniaephenotypic resistancewhole genome sequencingantibiotic resistance genehypervirulence

《中国人兽共患病学报》 2026 (4)

388-394,7

10.3969/j.issn.1002-2694.2026.00.033

评论